Grocer banner

GlaxoSmithKline (GSK)

Share Price:
Up 1,672.01p
Change Today:
5.61p
Market Cap:
83,407m

Company Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Competitors: ProStrakan, Shire Plc, Asterand, AstraZeneca, Skyepharma
Registrars: Equiniti
Brands: Lucozade, Horlicks, Ribena, Paxil, Seroxat

Key Personnel

Non-Executive Chairman: Philip R Hampton
CEO: Emma Walmsley
CFO: Iain Mackay
Chief Scientific Officer: Hal Barron
Executive Director: Simon Dingemans
Independent Non-Executive Director: Vivienne Cox
Independent Non-Executive Director: Urs Rohner
Independent Non-Executive Director: Judy Lewent
Independent Non-Executive Director: Lynn Elsenhans
Independent Non-Executive Director: Laurie Glimcher
Independent Non-Executive Director: Jesse Goodman
Senior Independent Non-Executive Director: Manvinder Singh Banga
Non-Executive Dir:

Contact Details

Address: 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS
Phone: +44 (0)20 8047 5000
Fax: +44 (0)20 8047 7807
Website: http://www.gsk.com

Listings

Sector: Pharma and Biotech(LSE)
Overseas Listings: BATSLON:GSKL, NYSE:GSK
ISIN: GB0009252882

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Market Data

Currency UK Pounds
Price 1,672.01p
Change Today 5.61p
52 Week High 1,730.00p
52 Week Low 1,418.00p
Volume 759,106
Shares Issued 4,988.42m
Market Cap 83,407m

Dividends

  Latest Previous
  Q2 Q1
Ex-Div 08-Aug-19 16-May-19
Paid 10-Oct-19 11-Jul-19
Amount 19.00p 19.00p